Pharma giant forecasted COVID-19 vaccine sales for 2023 would miss the average Wall Street estimate by more than $2.5 billion
Pharma giant forecasted COVID-19 vaccine sales for 2023 would miss the average Wall Street estimate by more than $2.5 billion
